WikiTrademarks - Search, analyse, and monitor trademark applications.

Trademark: RESTASIS

Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io

Tweet this

Track updates on RESTASIS

Proof of use for RESTASIS

We do not have any records of a proof of use for RESTASIS at this moment.

Click here to add a proof of use for RESTASIS

Possible trademark infringements of RESTASIS

Basic Information about RESTASIS

Serial Number
78041554
Filing Date
03 Jan 2001
Registration Number
2738873
Registration Date
15 Jul 2003
Mark Drawing Code
1

Classifications

Declare the trademark use of RESTASIS on the blockchain with WikiTrademarks.io.

First use of RESTASIS anywhere
RESTASIS was first used on 29 Oct 1997 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
6
International Code
005
US Codes
006; 018; 044; 046; 051; 052

Who owns RESTASIS?

1. Allergan, Inc. North Chicago IL

2. Allergan, Inc. Irvine CA

3. Allergan, Inc. Irvine CA

Correspondent

Cheryl A. Withycombe
AbbVie Inc.
18655 Teller Avenue
Mail code: AND-250C

Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io

Tweet this

Track updates on RESTASIS